| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5497777 | Applied Radiation and Isotopes | 2017 | 13 Pages |
Abstract
Thorium-229 is a valuable, but scarce, radionuclide for nuclear clock applications or targeted alpha therapy. While it is mostly produced by the decay of 233U, 229Th can also be produced by neutron irradiation of 226Ra. At SCK
- CEN, capsules containing mainly 228Th (by-product of 226Ra irradiation) were characterized to quantify the present amounts of 229Th, 228Th, 227Ac, 226Ra with high resolution gamma spectroscopy, after a decay period of 40 years in which 228Th has decayed. High purity 229Th was quantified, and after recovery using radiochemical separation processes, it can be used to support ongoing research.
- CEN, capsules containing mainly 228Th (by-product of 226Ra irradiation) were characterized to quantify the present amounts of 229Th, 228Th, 227Ac, 226Ra with high resolution gamma spectroscopy, after a decay period of 40 years in which 228Th has decayed. High purity 229Th was quantified, and after recovery using radiochemical separation processes, it can be used to support ongoing research.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sven Boden, Koen Vints, Simone Cagno, Dominic Maertens, Karen Van Hecke, Thomas Cardinaels,